AEGiS-UPI: AIDS conference tries to close gaps United Press InternationalImportant note: Information in this article was accurate in 1998. The state of the art may have changed since the publication date.
Click here to return to United Press International main menu
DonateNow
Print this article




AIDS conference tries to close gaps

United Press International; Thursday June 25 6:20 PM EDT
Ed Susman, UPI Science News


GENEVA, Switzerland, June 25 (UPI) - More than 10,000 doctors, scientists and activists converge on Geneva to spend a week sorting through thousands of reports on progress and failure in combating the worldwide epidemic in AIDS. Key presentations will discuss growing incidences of side effects of protease inhibitors _ still a mainstay of treatment, and ways of treating HIV/AIDS infection with fewer doses of drugs to help those with infection comply with treatment regimens.

The theme of the XIIth World AIDS Conference, "Bridging the Gap," also will explore the widening abyss between those who can afford treatment and the vast majority of the 30 million people living with HIV who do not have access to medication.

Robin Gorna, executive director of the Australian Federation of AIDS Organization and the community planning committee chairman of the conference, says, "Gaps in prevention, research and human rights will be addressed in all major sessions, as will urgent social and political issues such as access to treatment for people living with HIV in the developing world."

Even though costs of some drugs are decreasing, Dr. Peter Piot, executive director of UNAIDS in Geneva, says the costs are still prohibitive for people in Asia and sub-Saharan Africa, where 80 percent of the people with HIV infection live.

Dr. Bernard Hirschel of Geneva, chairman of the biannual conference, says highlights of the meeting, which opens Sunday and continues until July 3 will be:

_New information on side effects of protease inhibitors. The drugs which are credited with the ability to lower bloodstream virus to undetectable levels also

_ in a few patients _ create unsightly "buffalo" humps on the back or protruding bellies. The disfiguring changes in fat distribution in the body have caused some patients to stop taking the drugs.

_Studies that show that treating patients with minimal doses of protease inhibitors also work to impressively reduce the vial load in the body.

_The latest studies on new drugs which are most likely to be approved for use within the next year.

_Development of new treatment regimens that can significantly reduce the number of pills a patient has to take each day. In some AIDS regimens, 20 or more tablets are taken each day. Some have to be eaten with meals, others are taken on empty stomachs. The regimens can be difficult to follow and lead patients to not comply with treatment _ and that allows the disease to rebound.

The conference, last held two years ago in Vancouver, Canada, will study scientific reports submitted from 136 countries.

In developing countries, the news of the epidemic remains grim with rising prevalence rates among adults, young men and women and among children. Doctors in a few Third World nations _ Uganda and Thailand in particular _ will discuss how strong government action has reduced infection rates.

Piot says that while prevention works in some countries, it fails in others due to education, communication and cultural problems. He says a vaccine for AIDS is the key to controlling the epidemic in developing nations.

Even though AIDS vaccine trials have begun in the United States, Piot says he expects it will be at least 10 years before a successful vaccine is ready for use in mass populations.

Piot says the gap between the raging epidemic in Asia and Africa will be seen in reports showing that the epidemic is slowing or is in decline in industrialized parts of the world where there is easy access to information and medication.

Although the international conferences were once noted for protests by AIDS patients, activists outbursts were infrequent and relatively informative in nature in Vancouver. Officials say they expect any activism at Geneva to be low key as well.


980625
UP980614


Copyright © 1998 - United Press International. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through United Press International, Permissions Desk, 1510 H St. N.W. Washington DC 2005. Main Phone Switchboard: 202-898-8000 FAX: 202-898-8057 or 202-898-8147 Email: info@upi.com.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation UK, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 1998. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1998. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .